Utah Medical Products (UTMD) Competitors $52.30 -0.10 (-0.19%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$52.46 +0.16 (+0.31%) As of 04/17/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock UTMD vs. CERS, OSUR, ANIK, COO, WST, ALGN, MMSI, ICUI, HAE, and XRAYShould you be buying Utah Medical Products stock or one of its competitors? The main competitors of Utah Medical Products include Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), Cooper Companies (COO), West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry. Utah Medical Products vs. Cerus OraSure Technologies Anika Therapeutics Cooper Companies West Pharmaceutical Services Align Technology Merit Medical Systems ICU Medical Haemonetics DENTSPLY SIRONA Cerus (NASDAQ:CERS) and Utah Medical Products (NASDAQ:UTMD) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, community ranking, institutional ownership, risk, profitability and valuation. Which has more volatility and risk, CERS or UTMD? Cerus has a beta of 1.7, meaning that its stock price is 70% more volatile than the S&P 500. Comparatively, Utah Medical Products has a beta of 0.17, meaning that its stock price is 83% less volatile than the S&P 500. Is CERS or UTMD more profitable? Utah Medical Products has a net margin of 33.92% compared to Cerus' net margin of -11.60%. Utah Medical Products' return on equity of 11.07% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Cerus-11.60% -40.55% -11.12% Utah Medical Products 33.92%11.07%10.53% Does the MarketBeat Community favor CERS or UTMD? Cerus received 416 more outperform votes than Utah Medical Products when rated by MarketBeat users. Likewise, 72.34% of users gave Cerus an outperform vote while only 61.60% of users gave Utah Medical Products an outperform vote. CompanyUnderperformOutperformCerusOutperform Votes57072.34% Underperform Votes21827.66% Utah Medical ProductsOutperform Votes15461.60% Underperform Votes9638.40% Does the media prefer CERS or UTMD? In the previous week, Cerus and Cerus both had 4 articles in the media. Cerus' average media sentiment score of 1.44 beat Utah Medical Products' score of 0.56 indicating that Cerus is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cerus 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Utah Medical Products 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has better valuation & earnings, CERS or UTMD? Utah Medical Products has lower revenue, but higher earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCerus$180.27M1.34-$37.49M-$0.11-11.82Utah Medical Products$40.90M4.20$13.87M$3.9513.24 Do institutionals and insiders believe in CERS or UTMD? 78.4% of Cerus shares are owned by institutional investors. Comparatively, 69.6% of Utah Medical Products shares are owned by institutional investors. 3.4% of Cerus shares are owned by insiders. Comparatively, 6.6% of Utah Medical Products shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts rate CERS or UTMD? Cerus currently has a consensus price target of $3.50, indicating a potential upside of 169.23%. Given Cerus' stronger consensus rating and higher probable upside, equities research analysts plainly believe Cerus is more favorable than Utah Medical Products.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Utah Medical Products 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryCerus beats Utah Medical Products on 9 of the 17 factors compared between the two stocks. Get Utah Medical Products News Delivered to You Automatically Sign up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UTMD vs. The Competition Export to ExcelMetricUtah Medical ProductsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$171.65M$4.05B$5.28B$7.34BDividend Yield2.31%39.51%5.11%4.31%P/E Ratio13.2427.7421.7017.76Price / Sales4.2050.02378.5597.71Price / Cash9.5951.0838.1534.64Price / Book1.485.826.433.98Net Income$13.87M$67.09M$3.20B$247.33M7 Day Performance-1.13%3.57%4.99%4.38%1 Month Performance-9.72%-6.36%-9.72%-7.77%1 Year Performance-22.66%12.88%10.86%1.25% Utah Medical Products Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UTMDUtah Medical Products2.7839 of 5 stars$52.30-0.2%N/A-22.7%$171.65M$40.90M13.24180Upcoming EarningsNews CoverageCERSCerus2.5861 of 5 stars$1.24flat$4.00+222.6%-20.7%$230.38M$180.27M-11.27290News CoveragePositive NewsGap UpOSUROraSure Technologies4.7112 of 5 stars$3.01-3.2%$5.50+82.7%-43.0%$225.15M$185.83M20.07840Positive NewsANIKAnika Therapeutics3.9534 of 5 stars$13.92-0.6%$22.00+58.0%-45.4%$197.33M$119.91M-2.09300Analyst ForecastNews CoveragePositive NewsCOOCooper Companies3.2429 of 5 stars$73.31-0.6%$110.25+50.4%-11.5%$14.66B$3.93B37.6016,000WSTWest Pharmaceutical Services4.6355 of 5 stars$201.28-0.9%$332.50+65.2%-46.5%$14.55B$2.89B30.0910,700Upcoming EarningsAnalyst RevisionHigh Trading VolumeALGNAlign Technology4.6616 of 5 stars$153.35-0.1%$262.64+71.3%-42.9%$11.23B$4.00B27.3421,610Positive NewsHigh Trading VolumeMMSIMerit Medical Systems4.7784 of 5 stars$92.51+0.0%$111.70+20.7%+27.1%$5.46B$1.36B45.356,950Upcoming EarningsShort Interest ↓Positive NewsHigh Trading VolumeICUIICU Medical3.9339 of 5 stars$142.25+2.1%$168.67+18.6%+44.6%$3.49B$2.38B-31.1314,500Analyst UpgradeHAEHaemonetics4.5782 of 5 stars$58.96-3.2%$101.22+71.7%-32.7%$2.96B$1.37B23.212,820Short Interest ↓Positive NewsXRAYDENTSPLY SIRONA4.8153 of 5 stars$13.24-2.5%$23.33+76.2%-57.7%$2.63B$3.79B-6.4015,000Analyst Downgrade Related Companies and Tools Related Companies Cerus Alternatives OraSure Technologies Alternatives Anika Therapeutics Alternatives Cooper Companies Alternatives West Pharmaceutical Services Alternatives Align Technology Alternatives Merit Medical Systems Alternatives ICU Medical Alternatives Haemonetics Alternatives DENTSPLY SIRONA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UTMD) was last updated on 4/18/2025 by MarketBeat.com Staff From Our Partners🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Utah Medical Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Utah Medical Products With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UTMD Stock Free UTMD Stock Alerts